The Human Fertilisation and Embryology (Amendment) (EU Exit) Regulations 2019
Jurisdiction | UK Non-devolved |
Citation | SI 2019/482 |
Year | 2019 |
-
“the third Directive” means—
- (a) in the application of this Act in relation to Great Britain, Commission Directive 2006/86/EC of 24 October 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards traceability requirements, notification of serious adverse reactions and events and certain technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells (“the 2006 Directive”) , as it had effect immediately before 29 April 2015 (which is the date on which the amendments made by Commission Directive 2015/565/EU came into force) , and
- (b) in the application of this Act in relation to Northern Ireland, the 2006 Directive as amended by Commission Directive 2015/565/EU,
- “tissue establishment” means a tissue bank or a unit of a hospital or another body which procures, tests, processes, preserves, stores or distributes human F14gametes or embryos,
- (2B) Any reference in this Act to a requirement of a provision of the first, second, third or fourth Directive—
- (a) in the application of this Act in relation to Great Britain, is to be read as a reference to a requirement which that provision would require to be imposed if the provision formed part of the law of England and Wales or Scotland, and
- (b) in the application of this Act in relation to Northern Ireland, is to be read as a reference to a requirement which that provision requires to be imposed.
- “(1A) For the purposes of subsection (1) , F16as it applies in relation to Great Britain, Article 24 of the first Directive is to be read subject to the modifications set out in paragraph 11A(8) of Schedule 3A.
- (4) “Third country” means—
- (a) in relation to the import of qualifying gametes or embryos into, or the export of qualifying gametes or embryos from, Great Britain, a country other than the United Kingdom,
- (b) in relation to the import of qualifying gametes or embryos into Northern Ireland, a country other than Northern Ireland or an EEA state, and
- (c) in relation to the export of qualifying gametes or embryos from Northern Ireland, a country other than the United Kingdom or an EEA state.
- (3) In relation to Northern Ireland, the Authority must take steps to enable the information specified in Annex VIII to be recorded in the EU Tissue Establishment Compendium in relation to each holder of a relevant licence.
- (5) The Authority must take the steps mentioned in subsection (3) to enable the information mentioned in that subsection to be recorded before the end of the period of 10 working days beginning with the day on which the person becomes the holder of a relevant licence.
- “relevant state” means an EEA State,
- (c) in relation to Northern Ireland, between premises referred to in paragraphs (a) and (b) and tissue establishments accredited, designated, authorised or licensed under the laws, or other measures, of an EEA state which implement the first, second and third Directives,
- (4) Directions may authorise any person to whom a licence applies to—
-
(a) receive gametes, embryos or human admixed embryos—
(i) from outside the United Kingdom, and (ii) in respect of Northern Ireland, from Great Britain, or - (b) send gametes, embryos or human admixed embryos outside the United Kingdom, in such circumstances and subject to such conditions as may be specified in the directions.
- (4AD) Where the Authority gives any directions under subsection (4) authorising any person to whom a licence applies to make any qualifying imports, it must—
- (a) in relation to Great Britain, provide that person with a certificate of authority in such form as the Authority considers appropriate; and
- (b) in relation to Northern...
To continue reading
Request your trial